Healthpeak Properties, Inc. $DOC Shares Purchased by HF Advisory Group LLC

HF Advisory Group LLC raised its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 27.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 119,490 shares of the real estate investment trust’s stock after acquiring an additional 25,747 shares during the quarter. HF Advisory Group LLC’s holdings in Healthpeak Properties were worth $1,963,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Norges Bank acquired a new position in shares of Healthpeak Properties in the 4th quarter valued at $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after buying an additional 7,007,777 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its position in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after acquiring an additional 4,776,056 shares during the period. Bank of New York Mellon Corp raised its position in shares of Healthpeak Properties by 42.7% in the fourth quarter. Bank of New York Mellon Corp now owns 9,641,231 shares of the real estate investment trust’s stock worth $155,031,000 after acquiring an additional 2,887,084 shares during the period. Finally, Millennium Management LLC boosted its stake in shares of Healthpeak Properties by 235.3% during the 4th quarter. Millennium Management LLC now owns 3,512,223 shares of the real estate investment trust’s stock worth $56,477,000 after acquiring an additional 2,464,612 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on DOC. Wells Fargo & Company lifted their price target on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. Scotiabank increased their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Wednesday, May 27th. Raymond James Financial began coverage on Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating on the stock. JPMorgan Chase & Co. boosted their price objective on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday. Finally, Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Three analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to MarketBeat, Healthpeak Properties presently has an average rating of “Hold” and a consensus target price of $19.93.

Healthpeak Properties Trading Up 1.3%

Shares of Healthpeak Properties stock opened at $21.51 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $21.56. The firm has a market capitalization of $14.83 billion, a PE ratio of 67.22, a P/E/G ratio of 3.31 and a beta of 1.05. The firm’s 50-day moving average price is $19.06 and its 200 day moving average price is $17.66.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which was paid on Friday, June 26th. Shareholders of record on Monday, June 15th were paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 5.7%. The ex-dividend date of this dividend was Monday, June 15th. Healthpeak Properties’s payout ratio is 381.25%.

Insider Activity

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.23% of the stock is owned by insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.